Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%

NCT04986202 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

711

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: AZD4831
OTHER: Placebo

Sponsor

AstraZeneca